Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only/idempotent annotations, the description discloses rich behavioral detail: internal cascade through multiple endpoints, graceful LEI/FIGI degradation, returning figi_candidates when a name is ambiguous, explicit unresolved identifiers, source-labelled results, and ISIN-to-LEI mapping for non-US issuers. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense and front-loaded with examples and the 'Use FIRST' directive. It uses labeled sections and parentheticals efficiently, though some material overlaps with the input schema's parameter descriptions, slightly reducing conciseness.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Even without an output schema, the description covers return behavior (figi_candidates, unresolved, source labels), edge cases (non-equity instruments, ambiguous names, issuer mismatches), input variants, and fallback behavior. An agent has enough context to invoke the tool correctly in a wide range of scenarios.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers both parameters thoroughly, but the description adds the important detail that ISIN is also accepted as input, which the schema's type description does not mention. It also adds context about how values are interpreted (e.g., bond issuer names exactly as printed), going beyond the basic parameter descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user queries and a precise statement: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It clearly identifies the verb, resource, and scope, and the 'Use FIRST whenever' directive differentiates it from sibling lookup tools like entity_profile and compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use FIRST whenever you have a name but need an ID,' giving immediate when-to-use guidance. It also enumerates supported entity types and the specific inputs each accepts, and notes that it 'replaces 2-3 manual lookups,' reinforcing the intended use case.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools are nearly indistinguishable in role: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are all variants of the same router, with the beta version explicitly noted as currently identical to the stable one. The six Polymarket tools also overlap heavily around edge-finding, arbitrage, and fill-risk analysis, making misselection likely.

Naming Consistency3/5

Names are uniformly snake_case and groupable into prefixes like polymarket_* and pipeworx_*, but the set does not follow a consistent verb_noun convention. Noun-first names like entity_profile and recent_alerts sit alongside verb-first names like read_feed and validate_claim, and product-name suffixes such as ask_pipeworx_beta/grounded add further inconsistency.

Tool Count2/5

At 34 tools, the surface is well past the 25+ threshold and far broader than the 'Crypto Feeds' name suggests. The set spans feed reading, general data research, prediction markets, AI-brand visibility audits, npm dependency scanning, memory, and subscriptions, making it feel like a platform-wide dump rather than a focused MCP server.

Completeness3/5

The broad research workflow is well covered with query, grounded answer, deep research, entity profiles, comparisons, fact-checking, and entity resolution. However, feed functionality is read-only with no feed management, subscription types do not include crypto feeds despite the server name, and there is no dedicated tool for resolving the advertised pipeworx:// citation URIs.